comparemela.com

Latest Breaking News On - Prnewswire biomica ltd - Page 1 : comparemela.com

Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

The final patient completes Phase I trial enrollment, evaluating safety and tolerability for Biomica s microbiome-based immuno-oncology drug, BMC128 REHOVOT, Israel, Jan. 17, 2024 /PRNewswire/ .

Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center

REHOVOT, Israel, Aug. 15, 2023 /PRNewswire/ Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. , has. -Today at 07:01 am- MarketScreener

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.